Transamerica Financial Advisors, Inc. Abb Vie Inc. Transaction History

Transamerica Financial Advisors, Inc.

$1.02 Billion
Q3 2024

A detailed history of Transamerica Financial Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Transamerica Financial Advisors, Inc. holds 4,997 shares of ABBV stock, worth $899,460. This represents 0.1% of its overall portfolio holdings.

Number of Shares

4,997

Previous 7,229 30.88%

Holding current value

$899,460

Previous $1.24 Million 20.4%

% of portfolio

0.1%

Previous 0.13%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $365,690 - $444,904	-2,232 Reduced 30.88%	4,997 $987,000
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $643,435 - $733,134	-4,026 Reduced 35.77%	7,229 $1.32 Million
Q4 2023 Feb 12, 2024	SELL	$137.6 - $154.97 $135,260 - $152,335	-983 Reduced 8.03%	11,255 $1.75 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $144,143 - $166,867	-1,079 Reduced 8.1%	12,238 $1.83 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $142,978 - $177,927	1,079 Added 8.82%	13,317 $1.8 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $113,085 - $130,234	-782 Reduced 6.01%	12,238 $1.95 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $217,146 - $260,415	-1,570 Reduced 10.76%	13,020 $2.11 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $218,628 - $250,751	1,629 Added 12.57%	14,590 $1.96 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $1.78 Million - $2.27 Million	12,961 New	12,961 $1.99 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $319 - $362	-3 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$105.21 - $117.21 $1,262 - $1,406	-12 Reduced 80.0%	3 $1,000
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $643 - $869	8 Added 114.29%	15 $2,000
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $1.36 Million - $1.6 Million	-15,826 Reduced 99.96%	7 $1,000
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $1.16 Million - $1.55 Million	15,833 New	15,833 $1.56 Million
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $160,473 - $192,934	-2,548 Closed	0 $0
Q2 2019 Aug 21, 2019	BUY	$65.7 - $83.98 $167,403 - $213,981	2,548 New	2,548 $186,000
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $204,652 - $240,865	-2,653 Closed	0 $0
Q4 2018 Feb 04, 2019	SELL	$77.85 - $96.01 $10,354 - $12,769	-133 Reduced 4.77%	2,653 $245,000
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $31,563 - $35,088	355 Added 14.6%	2,786 $264,000
Q2 2018 Jul 25, 2018	SELL	$89.78 - $106.23 $324,824 - $384,340	-3,618 Reduced 59.81%	2,431 $226,000
Q1 2018 May 09, 2018	BUY	$92.01 - $123.21 $556,568 - $745,297	6,049 New	6,049 $573,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Transamerica Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Transamerica Financial Advisors, Inc. with notifications on news.

Account

Transamerica Financial Advisors, Inc. Abb Vie Inc. Transaction History